Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

1.

Amphetamine Derivatives and the Risk of Pulmonary Arterial Hypertension: A Missing Chapter of the Story?

Frachon I.

Am J Respir Crit Care Med. 2018 May 15;197(10):1364. doi: 10.1164/rccm.201711-2319LE. No abstract available.

PMID:
29272590
2.

Evaluation of quantitative PCR for early diagnosis of Pseudomonas aeruginosa infection in cystic fibrosis: a prospective cohort study.

Héry-Arnaud G, Nowak E, Caillon J, David V, Dirou A, Revert K, Munck MR, Frachon I, Haloun A, Horeau-Langlard D, Le Bihan J, Danner-Boucher I, Ramel S, Pelletier MP, Rosec S, Gouriou S, Poulhazan E, Payan C, Férec C, Rault G, Le Gal G, Le Berre R.

Clin Microbiol Infect. 2017 Mar;23(3):203-207. doi: 10.1016/j.cmi.2016.11.016. Epub 2016 Nov 27.

3.

Highlighting the impact of cascade carrier testing in cystic fibrosis families.

Duguépéroux I, L'Hostis C, Audrézet MP, Rault G, Frachon I, Bernard R, Parent P, Blayau M, Schmitt S, Génin E, Férec C, Scotet V.

J Cyst Fibros. 2016 Jul;15(4):452-9. doi: 10.1016/j.jcf.2016.02.013. Epub 2016 Mar 22.

4.

T-cell therapy using a bank of EBV-specific cytotoxic T cells: lessons from a phase I/II feasibility and safety study.

Gallot G, Vollant S, Saïagh S, Clémenceau B, Vivien R, Cerato E, Bignon JD, Ferrand C, Jaccard A, Vigouroux S, Choquet S, Dalle JH, Frachon I, Bruno B, Mothy M, Mechinaud F, Leblond V, Milpied N, Vié H.

J Immunother. 2014 Apr;37(3):170-9. doi: 10.1097/CJI.0000000000000031.

PMID:
24598452
5.

[About the settlement of litigations concerning the harm caused by benfluorex (Mediator®)].

Nicot P, Frachon I, Hill C.

Presse Med. 2013 Apr;42(4 Pt 1):411-8. doi: 10.1016/j.lpm.2013.02.310. Epub 2013 Mar 11. Review. French.

PMID:
23490638
6.

Pulmonary hypertension associated with benfluorex exposure.

Savale L, Chaumais MC, Cottin V, Bergot E, Frachon I, Prevot G, Pison C, Dromer C, Poubeau P, Lamblin N, Habib G, Reynaud-Gaubert M, Bourdin A, Sanchez O, Tubert-Bitter P, Jaïs X, Montani D, Sitbon O, Simonneau G, Humbert M.

Eur Respir J. 2012 Nov;40(5):1164-72. doi: 10.1183/09031936.00188611. Epub 2012 Apr 20.

7.

[Letter on the article: "benfluorex and valvular heart disease"].

Jobic Y, Etienne Y, Tribouilloy C, Bruneval P, Frachon I.

Presse Med. 2012 Mar;41(3 Pt 1):326-7. doi: 10.1016/j.lpm.2012.01.002. Epub 2012 Feb 6. French. No abstract available.

PMID:
22317843
8.

Benfluorex withdrawal in France: Still be hiding somewhere in the world?

Frachon I, Le Gal G, Hill C, Leroyer C.

J Pharmacol Pharmacother. 2011 Oct;2(4):307-8. doi: 10.4103/0976-500X.85942. No abstract available.

9.

Mitral and aortic valvular disease associated with benfluorex use.

Etienne Y, Jobic Y, Frachon I, Fatemi M, Castellant P, Quintin-Roué I.

J Heart Valve Dis. 2011 May;20(3):348-50.

PMID:
21714428
10.

[Benfluorex (Mediator®), our vigilance in question].

Frachon I.

Presse Med. 2011 May;40(5):459-61. doi: 10.1016/j.lpm.2011.02.019. Epub 2011 Apr 5. French. No abstract available.

PMID:
21470816
11.

[Contraception, therapeutic abortion, and pulmonary arterial hypertension].

Frachon I, Gaudin SP, Jezequel C, Jaïs X, Gut-Gobert C, Christophe SR, Humbert M, Leroyer C.

Presse Med. 2010 Jun;39 Suppl 1:1S46-50. doi: 10.1016/S0755-4982(10)70007-5. French.

PMID:
20732618
12.

Benfluorex and unexplained valvular heart disease: a case-control study.

Frachon I, Etienne Y, Jobic Y, Le Gal G, Humbert M, Leroyer C.

PLoS One. 2010 Apr 12;5(4):e10128. doi: 10.1371/journal.pone.0010128.

13.

[Pulmonary arterial hypertension in the elderly subject].

Frachon I, Barnier A, Jobic Y, Gut-Gobert C, Etienne Y, Crutu A, Mialon P, Pasquier E, Nowak E, Mejri M, Couturaud F, Leroyer C; le groupe HTAP de Bretagne Occidentale.

Rev Mal Respir. 2010;27(1):30-6. doi: 10.1016/j.rmr.2009.11.003. Epub 2009 Dec 16. French.

PMID:
20146949
14.

[Treatments targeting distal airways in asthma: update on clinical studies].

Burgel PR, Frachon I, Didier A, Dusser D.

Rev Mal Respir. 2009 Oct;26(8):859-66. Review. French.

PMID:
19953030
15.

Improvement of HIV-related pulmonary hypertension after the introduction of an antiretroviral therapy.

Barnier A, Frachon I, Dewilde J, Gut-Gobert C, Jobic Y, Leroyer C.

Eur Respir J. 2009 Jul;34(1):277-8. doi: 10.1183/09031936.00014209. No abstract available.

16.

Update on the roles of distal airways in asthma.

Burgel PR, de Blic J, Chanez P, Delacourt C, Devillier P, Didier A, Dubus JC, Frachon I, Garcia G, Humbert M, Laurent F, Louis R, Magnan A, Mahut B, Perez T, Roche N, Tillie-Leblond I, Tunon de Lara M, Dusser D.

Eur Respir Rev. 2009 Jun;18(112):80-95. doi: 10.1183/09059180.00001109. Review.

17.

Fenfluramine-like cardiovascular side-effects of benfluorex.

Boutet K, Frachon I, Jobic Y, Gut-Gobert C, Leroyer C, Carlhant-Kowalski D, Sitbon O, Simonneau G, Humbert M.

Eur Respir J. 2009 Mar;33(3):684-8. doi: 10.1183/09031936.00086308.

18.

Chronic thromboembolic pulmonary hypertension: a tribute to pulmonary endarterectomy.

Couturaud F, Frachon I, Leroyer C.

Eur Respir J. 2009 Feb;33(2):230-2. doi: 10.1183/09031936.00175508. No abstract available.

19.

Characterisation of severe obliterative bronchiolitis in rheumatoid arthritis.

Devouassoux G, Cottin V, Lioté H, Marchand E, Frachon I, Schuller A, Béjui-Thivolet F, Cordier JF; Groupe d'Etudes et de Recherche sur les Maladies "Orphelines" Pulmonaires (GERM"O"P).

Eur Respir J. 2009 May;33(5):1053-61. doi: 10.1183/09031936.00091608. Epub 2009 Jan 7.

20.

[Diagnosis and care of postembolic pulmonary hypertension: the role of the pneumologist].

Frachon I, Jaïs X, Leroyer C, Jobic Y, Huchot E, Simonneau G, Dartevelle P.

Rev Pneumol Clin. 2008 Dec;64(6):316-24. doi: 10.1016/j.pneumo.2008.09.009. Epub 2008 Nov 26. Review. French.

PMID:
19084211
21.

[Education of the adult asthmatic].

Couturaud F, Frachon I, Guillou-Bideau B, Leroyer C.

Rev Mal Respir. 2002 Feb;19(1):73-85. Review. French.

PMID:
17546816
22.

CFTR transgene expression in primary DeltaF508 epithelial cell cultures from human nasal polyps following gene transfer with cationic phosphonolipids.

Montier T, Delépine P, Marianowski R, Le Ny K, Le Bris M, Gillet D, Potard G, Mondine P, Frachon I, Yaouanc JJ, Clément JC, Des Abbayes H, Férec C.

Mol Biotechnol. 2004 Mar;26(3):193-206.

PMID:
15004288
23.

Education and self-management: a one-year randomized trial in stable adult asthmatic patients.

Couturaud F, Proust A, Frachon I, Dewitte JD, Oger E, Quiot JJ, Leroyer C.

J Asthma. 2002 Sep;39(6):493-500.

PMID:
12375708
24.

Quantification of CFTR splice variants in adults with disseminated bronchiectasis, using the TaqMan fluorogenic detection system.

Andrieux J, Audrézet MP, Frachon I, Leroyer C, Roge C, Scotet V, Férec C.

Clin Genet. 2002 Jul;62(1):60-7.

PMID:
12123489
25.

Pulmonary toxicity of chemotherapy and G/GM-CSF: a report of five cases.

Couderc LJ, Stelianides S, Frachon I, Stern M, Epardeau B, Baumelou E, Caubarrere I, Hermine O.

Respir Med. 1999 Jan;93(1):65-8. Review. No abstract available.

26.

[Report of 2 cases of pleural recurrences of surgically treated bronchogenic carcinoids. Diagnostic and therapeutic problems].

Bonnette P, Epardeau B, Frachon I, Bisson A, Caubarrere I, Mignot L, Corone C.

Rev Mal Respir. 1999 Feb;16(1):85-8. Review. French.

PMID:
10091265
27.

Accelerated obstructive pulmonary disease in HIV infected patients with bronchiectasis.

Bard M, Couderc LJ, Saimot AG, Scherrer A, Frachon I, Seigneur F, Caubarrere I.

Eur Respir J. 1998 Mar;11(3):771-5.

28.

Predictive value of cytomegalovirus DNA detection by polymerase chain reaction in blood and bronchoalveolar lavage in lung transplant patients.

Stéphan F, Fajac A, Grenet D, Honderlick P, Ricci S, Frachon I, Friard S, Caubarrere I, Bernaudin JF, Stern M.

Transplantation. 1997 May 27;63(10):1430-5.

PMID:
9175806
29.

Computed tomography of complications of lung transplantation.

Soyer P, Devine N, Frachon I, Vinatier I, Stern M, Normand SL, Scherrer A.

Eur Radiol. 1997;7(6):847-53.

PMID:
9228099
30.

Nebulized cyclosporine for prevention of acute pulmonary allograft rejection in the rat: pharmacokinetic and histologic study.

Blot F, Tavakoli R, Sellam S, Epardeau B, Faurisson F, Bernard N, Becquemin MH, Frachon I, Stern M, Pocidalo JJ, et al.

J Heart Lung Transplant. 1995 Nov-Dec;14(6 Pt 1):1162-72.

PMID:
8719464
31.

[Cytomegalovirus pneumopathies. What role should be given to cytomegaloviruses isolated from blood and bronchoalveolar lavage fluid in AIDS and from organ and bone marrow grafts?].

Blot F, Mayaud C, Frachon I, Couderc LJ, Stern M, Friard S, Caubarrère I.

Rev Pneumol Clin. 1995;51(6):309-20. Review. French.

PMID:
8746018
32.

Particular phenotypic profile of blood lymphocytes during obliterative bronchiolitis syndrome following lung transplantation.

Fattal-German M, Frachon I, Cerrina J, Ladurie FL, Lecerf F, Dartevelle P, Berrih-Aknin S.

Transpl Immunol. 1994 Sep;2(3):243-51.

PMID:
7528088
33.

Transforming growth factor beta in normal human lung: preferential location in bronchial epithelial cells.

Magnan A, Frachon I, Rain B, Peuchmaur M, Monti G, Lenot B, Fattal M, Simonneau G, Galanaud P, Emilie D.

Thorax. 1994 Aug;49(8):789-92.

34.

Emergence of inflammatory alveolar macrophages during rejection or infection after lung transplantation.

Frachon I, Fattal-German M, Magnan A, Cerrina J, Le Roy Ladurie F, Parquin F, Rain B, Lecerf F, Dartevelle P, Emilie D, et al.

Transplantation. 1994 Jun 15;57(11):1621-8.

PMID:
7516588

Supplemental Content

Loading ...
Support Center